alpha-cancer.com
Contact us
About company
Alpha Cancer Technologies Inc. (ACT) is a private clinical stage biotechnology company with products under development in immunotherapy and immuno-oncology. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP).
Unknown
Unknown
Not verified company
